Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-490-1 | CAS number: 70236-60-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From February 18th to May 12th, 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted according to internationally accepted testing guidelines and performed according to GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Disodium [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- EC Number:
- 274-490-1
- EC Name:
- Disodium [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- Cas Number:
- 70236-60-1
- Molecular formula:
- C36H21CrN8O11S.2Na
- IUPAC Name:
- disodium [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)-
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF breeding, VELAZ s.r.o., Únětice, Czech Republic, RČH CZ 21760118.
- Weight at study initiation: 215 - 216 g.
- Housing: SPF animal house according to the guideline.
- Acclimation period: at least 5 days.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle used: aqua pro injection
- Duration of treatment / exposure:
- 21-day application period
Doses / concentrations
- Remarks:
- Doses / Concentrations:
50, 125, 500 and 1000 mg/kg/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 20 females, 5 per dose-group
- Control animals:
- yes, concurrent vehicle
Examinations
- Tissues and cell types examined:
- Bone marrow and peripheral blood.
- Details of tissue and slide preparation:
- BONE MARROW HARVESTING
Bone marrow cells were from the femora immediately after euthanasia of animals.
After excising and careful cleaning of the bone both femur ends were clipped off Marrow was gently flushed from the bone by 1 ml of bovine serum into the tube. Acquired bone marrow was mixed several times by syringe with thin needle.
Preparation of the bone marrow smears
The bone marrow with serum in tubes was centrifuged (5 min - 1000 rpm). The supernatant was gently removed, one drop of bovine serum was added to the sediment and this cell suspension was mixed on mixer. Clean and degreased slides were marked by the number of study, number of animal, sex and dose level. One drop of cell suspension was placed onto the slide and a smear was prepared using a pusher slide. Two bone marrow smears were prepared per animal.
Staining of the bone marrow smears
After drying (20 minutes, 60 °C) the smears were fixed by ethanol - 5 minutes. Then they were twice rinsed by distilled water and stained by 5 % solution of Giemsa - 15 minutes.
PERIPHERAL BLOOD SMEARS
The blood samples were collected from the orbital plexus by glass micropipette under the light ether narcosis into the PVC test tubes containing anticoagulation systems. Smears preparations were made and then stained. The frequency of micronuclei was scored in mature normochromatic erythrocytes (NCE).
Four slides from each animal were made.
EXAMINATION
Stained bone marrow smears and peripheral blood smears were coded and examined blindly using light microscopy.
At bone marrow smears the incidence of micronucleated cells per 2000 polychromatic erythrocytes (PCE - blue stained immature cells) per animal was scored.
The ratio of polychromatic (immature erythrocytes) among 200 total normochromatic erythrocytes per animal was calculated together with appropriate group mean values and standard deviations to identify toxicity of the test substance.
For peripheral blood smears examination, about 4000 mature normochromatic erythrocytes from each animal were scored. The frequency of micronuclei was scored in mature normochromatic erythrocytes (NCE). The final number of mieronuclei was adjusted for 1000 erythrocytes per animal. - Evaluation criteria:
- A comparison was made between the number of micronucleated polychromatic erythrocytes (in case of the bone marrow) and norrnochromatic erythrocytes (in case of the blood) occurring in each of the test group and the number occurring in the corresponding vehicle control group.
Genotoxic activity is indicated by a statistically significant, dose-related increase in the incidence of micronucleated immature erythrocytes for the treatment group compmed with the negative control group.
If these criteria are not demonstrated, then the test material is considered to be non-genotoxic under the conditions of the test.
A positive response for bone marrow toxicity is demonstrated when the dose group mean polychromatic to normochromatic ratio is statistically lower than the concurrent vehicle control group. - Statistics:
- The Excel software was used for calculation of mean values and standard deviations for each group of animals.
The statistical analysis was performed by the non-parametric Kruskal-Wallis test for the comparison of the measured effect in all treatment groups with the vehicle control group, as global test. Mann- Whitney test was used for confirmation of results.
Results and discussion
Test results
- Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Remarks:
- test substance did not significantly affect the formation of new erythrocytes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Additional information on results:
- Statistically significant increase in the number of micronucleated polycbromatic erythrocytes in the bone marrow and normochromatic erythrocytes in peripheral blood compared to the control was not recorded at any dose level.
Negative results in the micronucleus test indicate that under the test conditions, the test substance does not produce micronuclei in polychromatic erythrocytes in bone marrow and normochromatic erythrocytes in peripheral blood of rat.
The test substance is considered to be non-genotoxic under the condition of the test.
Any other information on results incl. tables
Proportion of immature erythrocytes among total erythrocytes - "cytotoxicity index"
The number of 200 erythrocytes was evaluated per animal for the proportion of polychromatic (immature) and mature erythrocytes (index cytotoxicity) in bone marrow.
In any group of animals administered by test substance, statistically significant changes of proportion of immature erythrocytes from total number of erythrocytes were not found out.
Comparison of values between treated groups and control group revealed that the test substance did not significantly affect the formation of new erythrocytes.
Cytotoxicity index - group means and standard deviations
Group | Mean | Standard deviation |
1000 mg/kg | 0.401 | 0.05 |
500 mg/kg | 0.397 | 0.06 |
125 mg/kg | 0.422 | 0.05 |
50 mg/kg | 0.381 | 0.05 |
Negative control | 0.388 | 0.05 |
Number of micronucleated polychramatic erythrocytes
In any group of animals administered by test substance, statistically significant changes of number of micronucleated polychromatic erythrocytes were not found out.
The number of polychromatic erythrocytes with micronuclei was slightly increased in animals of the dose 500 mg/kg, but the result is not statistically significant.
Micronucleated polychromatic erythrocytes - group means and standard deviations
Group | Number of micronucleated PCE per animal (per 2000 PCE) | Percentage expression | ||
Mean | Standard deviation | Mean | Standard deviation | |
1000 mg/kg | 2.17 | 0.83 | 0.109 | 0.04 |
500 mg/kg | 2.37 | 1.13 | 0.119 | 0.06 |
125 mg/kg | 2.17 | 0.82 | 0.109 | 0.04 |
50 mg/kg | 1.98 | 0.99 | 0.099 | 0.05 |
Negative control | 1.98 | 0.7 | 0.099 | 0.03 |
Examination of the peripheral blood smears
The frequency of micronuclei was scored in mature normochromatic erythrocytes (NCE) in the circulating blood obtained from the eye socket of the rat.
Red blood samples were collected at the termination of Dose Range Finding Experiment from treated females only; Slides were prepared, fixed and stained as for the bone marrow studies. Four slides from each animal were made. About 4000 mature red blood cells from each animal were scored. The count of micronuclei from treated animals was compared with the count hom negative control group of animals.
Micronucleated erythrocytes - gong means and standard deviations
Group | Number of micronucleated NCE per animal (per 1000 NCE) | |
Mean | Standard deviation | |
1000 mg/kg | 0.98 | 0.39 |
500 mg/kg | 0.84 | 0.48 |
125 mg/kg | 0.85 | 0.71 |
50 mg/kg | 0.79 | 0.32 |
Negative control | 0.79 | 0.37 |
NCE - normochromatic (mature) erythrocytes
A dose-related increase in the number of mNCE was observed up to the dose of 1000 mg/kg, though the modulation in the number of micronucleated erythrocytes is not statistically significant.
In any group of animals administered by test substance, statistically significant changes of number of micronucleated erythrocytes were not found out.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The test substance is considered to be non-genotoxic under the condition of the test. - Executive summary:
Method
The examination of the bone marrow and peripheral blood was performed with females only. At the termination of the Dose Range Finding Experiment with the test substance performed for Combined Study, the bone marrow harvesting and the blood taking was done.
Extra negative control group of 5 females, treated with vehicle only (aqua pro injection), was added to the DRF experiment. Positive control group of animals normally used in micronucleus test was waived.
Evaluation and interpretation of results was performed according to OECD Test Guideline 474 (1997) Mammalian Erythrocyte Micronucleus Test.
Results
Statistically significant increase in the number of micronucleated polycbromatic erythrocytes in the bone marrow and normochromatic erythrocytes in peripheral blood compared to the control was not recorded at any dose level.
Negative results in the micronucleus test indicate that under the test conditions, the test substance does not produce micronuclei in polychromatic erythrocytes in bone marrow and normochromatic erythrocytes in peripheral blood of rat.
The test substance is considered to be non-genotoxic under the condition of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.